Related Experiment Video
Updated: Aug 6, 2026

Visualization of Pseudomonas aeruginosa within the Sputum of Cystic Fibrosis Patients
Published on: July 16, 2020
[Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC]
Marco Somaschini1, Alessandra Cavazza, Silvia Riva
1Divisione di Patologia Neonatale, Ospedale Bolognini, Seriate. marco.somaschini@bolognini.bg.it
Insights
Mutations in the surfactant protein C (SP-C) gene (SFTPC) can cause interstitial lung disease. This study found the 173T mutation in a large family, revealing varied lung conditions and incomplete penetrance.
Area of Science:
- Genetics
- Pulmonology
- Molecular Biology
Background:
- Mutations in the SFTPC gene encoding surfactant protein C (SP-C) are linked to chronic interstitial lung disease (ILD).
- A pediatric patient with ILD was identified as heterozygous for the 173T mutation in SFTPC, a known ILD-associated variant.
Observation:
- A comprehensive study of a 25-member family revealed the 173T mutation in SP-C was present in individuals with diverse respiratory diseases, including restrictive pneumopathy, emphysema, asthma, pneumonia, and pulmonary fibrosis.
- Affected family members exhibited varied clinical presentations, ages of onset, and disease courses, suggesting incomplete penetrance of the mutation.
- The mutation was also detected in asymptomatic family members and others with unavailable clinical data.
Findings:
- Heterozygosity for the 173T SP-C mutation is confirmed to potentially cause chronic lung inflammation or progressive pulmonary fibrosis.
- Genotype-phenotype correlation within this large pedigree demonstrated significant variability in clinical manifestations.
Implications:
- The diverse clinical spectrum associated with the 173T mutation highlights the complexity of ILD pathogenesis.
- Incomplete penetrance suggests that other genetic or environmental factors may modify the expression and severity of SP-C related lung diseases.
Abstract:
Mutations in the gene encoding surfactant protein C (SP-C) SFTPC have been found to be associated with chronic interstitial lung disease. A 5-year-old girl oxygen dependent from birth and affected by interstitial lung disease (ILD) is heterozygous for a T to C change in exon 3 resulting in the substitution of threonine for isoleucine at codon 73 (173T), already described in association with ILD. We studied 25 members of her family where the 173T mutation in the SP-C gene is associated to chronic pulmonary diseases. Five members in the mother's family showed respiratory diseases with great diversity in clinical features: her mother was affected by restrictive pneumopathy and emphysema, her grand-mother by asthma and recurrent pneumonia, 2 uncles underwent lung transplantation in the adult age, an aunt was clinically diagnosed having pulmonary fibrosis. All the family members affected by pulmonary diseases and one with no clinical symptoms showed the presence of the mutation 173T. Among the other family members the mutation was found in six subjects for whom no clinical data were available, yet. Our results confirm that heterozygosity for the mutation 173T may cause chronic inflammation of the lung or progressive pulmonary fibrosis. In addition, the possibility to study a large pedigree allowed us to perform a genotype-phenotype correlation indicating a marked phenotypic variability. The diversity in symptoms, age at onset, clinical course, duration of lung disease in the relatives sharing this mutation indicates an incomplete penetrance of the mutation. This might be due to the influence of other genetic factors thus indicating that the phenotype may be complicated by additional components.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Pancreatitis II: Pathophysiology
Pneumonia I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Atypical Pneumonia
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
